Position in PFE
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$4,794,737
-$796,468 QoQ
Shares Held
199,117
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#612
of 2,821 holders
Holding Since
Sep 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026E. Ohman J:or Asset Management AB holds $142,928,858 across 9 Drug Manufacturers - General names. PFE ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
65,270 | $78,286,802 | |
| 2 | ABBV |
AbbVie Inc.
|
62,362 | $15,692,773 | |
| 3 | JNJ |
Johnson & Johnson
|
59,384 | $15,081,754 | |
| 4 | MRK |
Merck & Co., Inc.
|
87,897 | $11,294,764 | |
| 5 | AMGN |
Amgen Inc
|
19,515 | $7,066,771 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
44,792 | $5,659,021 | |
| 7 | PFE |
Pfizer Inc
This page
|
199,117 | $4,794,737 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
69,612 | $4,011,043 |
All Filings in PFE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,794,737 | 199,117 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $5,591,205 | 199,117 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $3,501,363 | 140,617 | Shares | Sole | 2026-01-12 | |
| 2024-06-30 | $6,799,140 | 243,000 | Shares | Sole | 2024-08-13 | |
| 2021-09-30 | $10,890,132 | 253,200 | Shares | Sole | 2024-04-05 | |
| 2021-06-30 | $9,508,048 | 242,800 | Shares | Sole | 2024-04-05 | |
| 2021-03-31 | $8,003,207 | 220,900 | Shares | Sole | 2024-04-05 | |
| 2020-12-31 | $4,166,892 | 113,200 | Shares | Sole | 2024-04-05 | |
| 2020-09-30 | $4,470,055 | 121,800 | Shares | Sole | 2024-04-05 | |
| No filing history on record for this holder in this stock. | ||||||